A paper on liver failure in infants has been retracted due to a lab error, though the author contends that the paper still holds a valuable message for pediatricians — one that could save lives.
To get to that, though, we had to make it through what turns out to be an unnecessarily vague retraction notice (more on that in a moment) in the Journal of Pediatric Gastroenterology & Nutrition:
Continue reading Paper on liver failure in babies withdrawn for lab mix-up
A paper in Immnunity has been retracted after two separate panels determined some of the figures “inappropriately presented” the data but cleared the team of wrongdoing.
However, the original data are now unavailable, according to the notice, so there’s no way to know if the paper’s conclusions are sound.
Here’s the notice for “Suppressors of Cytokine Signaling 2 and 3 Diametrically Control Macrophage Polarization”: Continue reading Immunology paper retracted for inappropriate presentation but “no evidence of intentional misconduct”
A year after an ORI report discredited the work of former University of Washington in Seattle researcher Andrew Aprikyan, one of the papers named in the report has finally been retracted.
Here’s the notice for “Impaired survival of bone marrow hematopoietic progenitor cells in cyclic neutropenia”: Continue reading A year after ORI report, hematology journal retracts faked paper
Another retraction has appeared up for frequent fliers Jun Li, Kailun Zhang and Jiahong Xia at Huazhong Science and Technology University in Wuhan, China.
We’ve covered them twice before, for a variety of retractions, corrections, and expressions of concern.
The retraction, in Clinical and Experimental Immunology, upgrades an expression of concern published earlier this year, and is the team’s fourth.
Here’s the notice for “CCR5 blockade in combination with rapamycin prolongs cardiac allograft survival in mice”: Continue reading Serial figure fakers have expression of concern upgraded to a retraction
A 2011 paper in PLOS ONE has been retracted due to “inappropriately assembled” images. The issues, which were highlighted in a correction in TK, are attributed to the corresponding author, Paola Palozza, who has since passed away.
Here’s the notice for “Lycopene Inhibits NF-kB-Mediated IL-8 Expression and Changes Redox and PPARγ Signalling in Cigarette Smoke–Stimulated Macrophages,” which has been cited 33 times, according to Thomson Scientific’s Web of Knowledge: Continue reading PLOS ONE retraction notice blames deceased author for image manipulation
Another stem cell paper has been retracted from Nature, this one a highly cited 2008 study that had already been the subject of what the journal’s news section called a “furore” in 2010.
According to that 2010 news story:
The researchers behind the original work1, led by Thomas Skutella of the University of Tübingen, reported using cells from adult human testes to create pluripotent stem cells with similar properties to embryonic stem cells.
But a 2010 Brief Communication Arising called those findings into question. And now, the authors have retracted the paper. Here’s the notice for “Generation of pluripotent stem cells from adult human testis:” Continue reading Another Nature stem cell paper is retracted
A stumble in data preparation earned a retraction for a paper on delirium tremens
, a life-threatening side effect of alcohol withdrawal that spans a wide range of symptoms, including hallucinations and seizures.
Though the initial retraction notice was extremely unhelpful, the author stepped in to give us a better picture of the errors that led to the paper’s demise.
Here’s the notice from Alcohol and Alcoholism about “Biochemical Predictors of Delirium Tremens in Patients in Alcohol Withdrawal”:
A research team at the University of Texas-Southwestern that has retracted eight papers for image manipulation has retracted another, this one in Lung Cancer.
Here’s the notice for “Aberrant methylation of Reprimo in lung cancer,” published by Adi Gazdar’s group: Continue reading UT-Southwestern cancer research group notches ninth retraction
A group of researchers at Stanford and elsewhere is retracting a 2013 paper that another scientist told Nature was “one of the biggest things to happen in the narcolepsy field for some time.”
The Science Translational Medicine paper caused a buzz because it claimed to show that narcolepsy was an autoimmune disease. Here’s the notice: Continue reading Authors retract paper “confirming” that narcolepsy is an autoimmune disease
A 2012 expression of concern prompted by an authorship dispute has been upgraded to a retraction.
As we reported in 2012, Revista Brasiliera de Reumatologia (aka the Brazilian Journal of Rheumatology) issued an expression of concern about “Anticitrullinated peptide antibodies and rheumatoid factor in Sudanese patients with Leishmania donovani infection” after
a claim from one of the authors, questioning the authorship of the corresponding author, and informed that the article was under submission to another journal.
The journal sought the advice of the Committee on Publication Ethics (COPE), and continued its investigation. That investigation is apparently now complete, and this retraction notice is the result: Continue reading Bitter rheumatology authorship dispute ends in retraction